You are currently viewing a new version of our website. To view the old version click .

Cancers | Top 10 Cited Papers in 2021 in the Section “Pediatric Oncology”

8 September 2022

1. “The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia”
by Lühmann, J. L.; Stelter, M.; Wolter, M.; Kater, J.; Lentes, J.; Bergmann, A. K.; Schieck, M.; Göhring, G.; Möricke, A.; Cario, G. et al.
Cancers 2021, 13(17), 4388; https://doi.org/10.3390/cancers13174388
Available online: https://www.mdpi.com/2072-6694/13/17/4388

2. “The Microbiome in Childhood Acute Lymphoblastic Leukemia”
by Oldenburg, M.; Rüchel, N.; Janssen, S.; Borkhardt, A.; Gössling, K. L.
Cancers 2021, 13(19), 4947; https://doi.org/10.3390/cancers13194947
Available online: https://www.mdpi.com/2072-6694/13/19/4947

3. “Plasticity in Neuroblastoma Cell Identity Defines a Noradrenergic-to-Mesenchymal Transition (NMT)”
by Gautier, M.; Thirant, C.; Delattre, O.; Janoueix-Lerosey, I.
Cancers 2021, 13(12), 2904; https://doi.org/10.3390/cancers13122904
Available online: https://www.mdpi.com/2072-6694/13/12/2904
 
4. “Pediatric Mixed-Phenotype Acute Leukemia: What’s New?”
by Batra, S.; Ross, A. J.
Cancers 2021, 13(18), 4658; https://doi.org/10.3390/cancers13184658
Available online: https://www.mdpi.com/2072-6694/13/18/4658
 
5. “Preliminary Radiogenomic Evidence for the Prediction of Metastasis and Chemotherapy Response in Pediatric Patients with Osteosarcoma Using 18F-FDG PET/CT, EZRIN, and KI67”
by Kim, B.-C.; Kim, J.; Kim, K.; Byun, B. H.; Lim, I.; Kong, C.-B.; Song, W. S.; Koh, J.-S.; Woo, S.-K.
Cancers 2021, 13(11), 2671; https://doi.org/10.3390/cancers13112671
Available online: https://www.mdpi.com/2072-6694/13/11/2671
 
6. “Unbalance in Iron Metabolism in Childhood Leukemia Converges with Treatment Intensity: Biochemical and Clinical Analysis”
by Łęcka, M.; Słomka, A.; Albrecht, K.; Żekanowska, E.; Romiszewski, M.; Styczyński, J.
Cancers 2021, 13(12), 3029; https://doi.org/10.3390/cancers13123029
Available online: https://www.mdpi.com/2072-6694/13/12/3029
 
7. “Natural History of Untreated Retinoblastoma”
by Zhao, J.; Feng, Z.; Gallie, B. L.
Cancers 2021, 13(15), 3646; https://doi.org/10.3390/cancers13153646
Available online: https://www.mdpi.com/2072-6694/13/15/3646
 
8. “Advances in the First Line Treatment of Pediatric Acute Myeloid Leukemia in the Polish Pediatric Leukemia and Lymphoma Study Group from 1983 to 2019”
by Czogała, M.; Balwierz, W.; Pawińska-Wąsikowska, K.; Książek, T.; Bukowska-Strakova, K.; Czogała, W.; Sikorska-Fic, B.; Matysiak, M.; Skalska-Sadowska, J.; Wachowiak, J. et al.
Cancers 2021, 13(18), 4536; https://doi.org/10.3390/cancers13184536
Available online: https://www.mdpi.com/2072-6694/13/18/4536
 
9. “Transcriptional and Mutational Profiling of B-Other Acute Lymphoblastic Leukemia for Improved Diagnostics”
by Chouvarine, P.; Antić, Ž.; Lentes, J.; Schröder, C.; Alten, J.; Brüggemann, M.; Carrillo-de Santa Pau, E.; Illig, T.; Laguna, T.; Schewe, D. et al.
Cancers 2021, 13(22), 5653; https://doi.org/10.3390/cancers13225653
Available online: https://www.mdpi.com/2072-6694/13/22/5653
 
10. “Overcoming PD-1 Inhibitor Resistance with a Monoclonal Antibody to Secreted Frizzled-Related Protein 2 in Metastatic Osteosarcoma”
by Nasarre, P.; Garcia, D. I.; Siegel, J. B.; Bonilla, I. V.; Mukherjee, R.; Hilliard, E.; Chakraborty, P.; Nasarre, C.; Yustein, J. T.; Lang, M. et al.
Cancers 2021, 13(11), 2696; https://doi.org/10.3390/cancers13112696
Available online: https://www.mdpi.com/2072-6694/13/11/2696